Patent ID: 11964047
Assignee: ETERNATEAR, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method of maintaining integrity of an eye's tear film layers which increases the eye's lipid layer thickness, the method comprising the step of:
administering an ophthalmic suspension to an eye of a patient in need of treatment, the ophthalmic suspension comprising:
i) an aqueous phase comprising water and one or more components selected from the group consisting of at least one wax ester, at least one anionic polar surfactant, at least one nonionic surfactant, at least one salt, and at least one phosphate; and)
ii) an oil phase comprising at least one mineral oil and, optionally, at least one wax ester,

wherein the ophthalmic suspension exhibits a Zeta potential of from about −60 mV to about −110 mV.